Lataa...
Immunosuppressive Treatment in Antiphospholipid Syndrome: Is It Worth It?
The antiphospholipid syndrome (APS) is characterized by the development of venous and/or arterial thrombosis and pregnancy morbidity in patients with persistent antiphospholipid antibodies (aPL). Catastrophic antiphospholipid syndrome (CAPS) is a life-threatening form of APS occurring in about 1% of...
Tallennettuna:
| Julkaisussa: | Biomedicines |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7911562/ https://ncbi.nlm.nih.gov/pubmed/33535377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9020132 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|